C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CCCC | CHRS | ELDN | ||
| Company | C4 Therapeutics Inc | Coherus Oncology Inc | Eledon Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.97 | 1.9400 | 3.83 | ||
| High | 3.02 | 1.9900 | 4.15 | ||
| Low | 2.87 | 1.8750 | 3.83 | ||
| Latest | 2.92 | 1.9800 | 3.98 | ||
| Change | +0.02 | +0.0800 | +0.25 | ||
| % Change | +0.69% | +4.21% | +6.70% | ||
| Volume | 1,139,400 | 1,755,100 | 4,471,300 | ||
| 20-Day Average Volume | 3,053,735 | 1,193,340 | 1,672,685 | ||
| Previous Close | 2.90 | 1.9000 | 3.73 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.70 | 1.7165 | 3.12 | ||
| 20-Day Raw Stochastic | 86.11% | 97.87% | 88.44% | ||
| 20-Day Relative Strength | 55.69 | 60.74 | 75.02 | ||
| Weighted Alpha | +48.43 | +83.02 | +118.43 | ||
| Today's Opinion | 96% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 88% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 56% Buy | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +15.19% since 04/10/26 | +17.86% since 04/10/26 | +28.39% since 04/10/26 | ||
| Low | 2.50 on 04/13/26 | 1.6200 on 04/13/26 | 3.10 on 04/13/26 | ||
| High | 3.02 on 04/17/26 | 1.9900 on 04/17/26 | 4.15 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +5.80% since 03/17/26 | +17.86% since 03/17/26 | +38.19% since 03/17/26 | ||
| Low | 2.30 on 03/30/26 | 1.5200 on 03/20/26 | 2.68 on 03/30/26 | ||
| High | 3.02 on 04/17/26 | 1.9900 on 04/17/26 | 4.15 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +30.94% since 01/16/26 | +23.75% since 01/16/26 | +87.74% since 01/16/26 | ||
| Low | 1.69 on 02/05/26 | 1.5103 on 01/20/26 | 1.96 on 02/05/26 | ||
| High | 3.82 on 03/09/26 | 2.6158 on 01/27/26 | 4.15 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +23.21% since 10/17/25 | +20.00% since 10/17/25 | +15.70% since 10/17/25 | ||
| Low | 1.69 on 02/05/26 | 1.0900 on 11/21/25 | 1.35 on 11/21/25 | ||
| High | 3.82 on 03/09/26 | 2.6158 on 01/27/26 | 4.60 on 11/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,976 | 284,791 | 282,928 | ||
| Shares Outstanding, K | 97,578 | 149,890 | 75,852 | ||
| Annual Sales | 35,950,000 | 42,170,000 | 0 | ||
| Annual Net Income | -104,990,000 | 168,020,000 | -45,620,000 | ||
| Last Quarter Sales | 11,020,000 | 12,750,000 | 0 | ||
| Last Quarter Net Income | -20,490,000 | -37,640,000 | -10,450,000 | ||
| 60-Month Beta | 2.85 | 1.03 | 0.83 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 02/26/26 | -0.34 on 03/09/26 | -0.10 on 03/19/26 | ||
| Latest Earnings Date | 05/06/26 | 05/11/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||